Cholesterol absorption decreases after Roux-en-Y gastric bypass but not after gastric banding

Metabolism: Clinical and Experimental

Volumn 59, Issue 6, 2010, Pages 866-872

  Pihlajamäki, Jussi ^a   Grönlund, Sari ^a   Simonen, Marko ^a   Käkelä, Pirjo ^a   Moilanen, Leena ^a   Pääkkönen, Matti ^a   Pirinen, Elina ^a   Kolehmainen, Marjukka ^a   Kärjä, Vesa ^a   Kainulainen, Sakari ^a   Uusitupa, Matti ^a   Alhava, Esko ^a   Miettinen, Tatu A ^b   Gylling, Helena ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AVENASTEROL; CAMPESTEROL; CHOLESTANOL; CHOLESTENOL; DESMOSTEROL; LATHOSTEROL; SITOSTEROL; SQUALENE; STEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; BODY MASS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GASTRIC BANDING; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LIPID ABSORPTION; LIPID ANALYSIS; MALE; MORBID OBESITY; NUTRITIONAL STATUS; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; ROUX Y ANASTOMOSIS; UNIVERSITY HOSPITAL; WEIGHT REDUCTION;

ADULT; ANASTOMOSIS, ROUX-EN-Y; BARIATRIC SURGERY; BLOOD GLUCOSE; BODY HEIGHT; BODY MASS INDEX; BODY WEIGHT; CHOLESTEROL; CHOLESTEROL, DIETARY; CHOLESTEROL, LDL; FEMALE; GASTRIC BYPASS; HUMANS; INTESTINAL ABSORPTION; LIVER; MALE; MIDDLE AGED; OBESITY; PHYTOSTEROLS; STEROLS;

EID: 77952270697     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.10.004     Document Type: Article

References (27)

1. Simonen P., Gylling H., Howard A.N., and Miettinen T.A. Introducing a new component of the metabolic syndrome: low cholesterol absorption. Am J Clin Nutr 72 (2000) 82-88
2. Simonen P., Gylling H., and Miettinen T.A. Acute effects of weight reduction on cholesterol metabolism in obese type 2 diabetes. Clin Chim Acta 316 (2002) 55-61
3. Adams T.D., Gress R.E., Smith S.C., Halverson R.C., Simper S.C., Rosamond W.D., et al. Long-term mortality after gastric bypass surgery. N Engl J Med 357 (2007) 753-761
4. Sjostrom L., Narbro K., Sjostrom C.D., Karason K., Larsson B., Wedel H., et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 357 (2007) 741-752
5. le Roux C.W., Aylwin S.J., Batterham R.L., Borg C.M., Coyle F., Prasad V., et al. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg 243 (2006) 108-114
6. Korner J., Bessler M., Inabnet W., Taveras C., and Holst J.J. Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding. Surg Obes Relat Dis 3 (2007) 597-601
7. le Roux C.W., Welbourn R., Werling M., Osborne A., Kokkinos A., Laurenius A., et al. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg 246 (2007) 780-785
8. Sauerland S., Angrisani L., Belachew M., Chevallier J.M., Favretti F., Finer N., et al. Obesity surgery: evidence-based guidelines of the European Association for Endoscopic Surgery (EAES). Surg Endosc 19 (2005) 200-221
9. Tice J.A., Karliner L., Walsh J., Petersen A.J., and Feldman M.D. Gastric banding or bypass? A systematic review comparing the two most popular bariatric procedures. Am J Med 121 (2008) 885-893
10. Brolin R.E., Bradley L.J., Wilson A.C., and Cody R.P. Lipid risk profile and weight stability after gastric restrictive operations for morbid obesity. J Gastrointest Surg 4 (2000) 464-469
11. Zlabek J.A., Grimm M.S., Larson C.J., Mathiason M.A., Lambert P.J., and Kothari S.N. The effect of laparoscopic gastric bypass surgery on dyslipidemia in severely obese patients. Surg Obes Relat Dis 1 (2005) 537-542
12. Nguyen N.T., Varela E., Sabio A., Tran C.L., Stamos M., and Wilson S.E. Resolution of hyperlipidemia after laparoscopic Roux-en-Y gastric bypass. J Am Coll Surg 203 (2006) 24-29
13. Corradini S.G., Eramo A., Lubrano C., Spera G., Cornoldi A., Grossi A., et al. Comparison of changes in lipid profile after bilio-intestinal bypass and gastric banding in patients with morbid obesity. Obes Surg 15 (2005) 367-377
14. Frige F., Laneri M., Veronelli A., Folli F., Paganelli M., Vedani P., et al. Bariatric surgery in obesity: changes of glucose and lipid metabolism correlate with changes of fat mass. Nutr Metab Cardiovasc Dis 19 (2009) 198-204
15. Martikainen T., Pirinen E., Alhava E., Poikolainen E., Paakkonen M., Uusitupa M., et al. Long-term results, late complications and quality of life in a series of adjustable gastric banding. Obes Surg 14 (2004) 648-654
16. Ferrannini E. The theoretical bases of indirect calorimetry: a review. Metabolism 37 (1988) 287-301
17. Brunt E.M., Janney C.G., Di Bisceglie A.M., Neuschwander-Tetri B.A., and Bacon B.R. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94 (1999) 2467-2474
18. Miettinen T.A., Tilvis R.S., and Kesäniemi Y.A. Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. Am J Epidemiol 131 (1990) 20-31
19. Simonen P., Gylling H., and Miettinen T.A. The validity of serum squalene and non-cholesterol sterols as surrogate markers of cholesterol synthesis and absorption in type 2 diabetes. Atherosclerosis 197 (2008) 883-888
20. Miettinen T.A. Cholesterol metabolism during ketoconazole treatment in man. J Lipid Res 29 (1998) 43-51
21. Silverman E.M., Sapala J.A., and Appelman H.D. Regression of hepatic steatosis in morbidly obese persons after gastric bypass. Am J Clin Pathol 104 (1995) 23-31
22. Johansson L., Roos M., Kullberg J., Weis J., Ahlstrom H., Sundbom M., et al. Lipid mobilization following Roux-en-Y gastric bypass examined by magnetic resonance imaging and spectroscopy. Obes Surg 18 (2008) 1297-1304
23. Valsta L.M., Lemstrom A., Ovaskainen M.L., Lampi A.M., Toivo J., Korhonen T., et al. Estimation of plant sterol and cholesterol intake in Finland: quality of new values and their effect on intake. Br J Nutr 92 (2004) 671-678
24. Hoenig M.R., Rolfe B.E., and Campbell J.H. Cholestanol: a serum marker to guide LDL cholesterol-lowering therapy. Atherosclerosis 184 (2006) 247-254
25. Olbers T., Bjorkman S., Lindroos A., Maleckas A., Lonn L., Sjostrom L., et al. Body composition, dietary intake, and energy expenditure after laparoscopic Roux-en-Y gastric bypass and laparoscopic vertical banded gastroplasty: a randomized clinical trial. Ann Surg 244 (2006) 715-722
26. Puri P., Baillie R.A., Wiest M.M., Mirshahi F., Choudhury J., Cheung O., et al. A lipidomic analysis of nonalcoholic fatty liver disease. Hepatology 46 (2007) 1081-1090
27. Caballero F., Fernandez A., De Lacy A.M., Fernandez-Checa J.C., Caballeria J., and Garcia-Ruiz C. Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH. J Hepatol 50 (2009) 789-796